Beta-lactams for the treatment of glaucoma, ocular hypertension, baldness and hair loss

Details for Australian Patent Application No. 2009205477 (hide)

Owner Allergan, Inc.

Inventors Dinh, Danny T.; Old, David W.; Burk, Robert M.

Agent Davies Collison Cave

Pub. Number AU-A-2009205477

PCT Pub. Number WO2009/091764

Priority 61/022,172 18.01.08 US; 12/352,903 13.01.09 US

Filing date 14 January 2009

Wipo publication date 23 July 2009

International Classifications

C07D 409/06 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

A61K 31/397 (2006.01) - having four-membered rings, e.g. azetidine

A61P 17/14 (2006.01) Drugs for dermatological disorders

A61P 27/02 (2006.01) Drugs for disorders of the senses

A61P 27/06 (2006.01) Drugs for disorders of the senses

C07D 205/08 (2006.01) Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom

Event Publications

12 August 2010 PCT application entered the National Phase

  PCT publication WO2009/091764 Priority application(s): WO2009/091764

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009205478-Therapeutic compounds

2009205473-Oxazolidine and thiazolidine selective subtype alpha 2 adrenergic agents and methods for use thereof